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Coxiella burnetii is an obligate intracellular bacterium that directs biogenesis of a parasitophorous vacuole
(PV) for replication. Effectors of PV maturation are likely translocated into the host cytosol by a type IV
secretion system (T4SS) with homology to the Dot/Icm apparatus of Legionella pneumophila. Since secreted
bacterial virulence factors often functionally mimic the activities of host proteins, prokaryotic proteins with
eukaryotic features are considered candidate T4SS substrates. Genes encoding proteins with eukaryotic-type
ankyrin repeat domains (Anks) were identified upon genome sequencing of the C. burnetii Nine Mile reference
isolate, which is associated with a case of human acute Q fever. Interestingly, recent genome sequencing of the
G and K isolates, derived from human chronic endocarditis patients, and of the Dugway rodent isolate revealed
remarkable heterogeneity in the Ank gene family, with the Dugway isolate harboring the largest number of
full-length Ank genes. Using L. pneumophila as a surrogate host, we identified 10 Dugway Anks and 1 Ank
specific to the G and K endocarditis isolates translocated into the host cytosol in a Dot/Icm-dependent fashion.
A 10-amino-acid C-terminal region appeared to be necessary for translocation, with some Anks also requiring
the chaperone IcmS for secretion. Ectopically expressed Anks localized to a variety of subcellular regions in
mammalian cells, including microtubules, mitochondria, and the PV membrane. Collectively, these data
suggest that C. burnetii isolates translocate distinct subsets of the Ank protein family into the host cytosol,
where they modulate diverse functions, some of which may be unique to C. burnetii pathotypes.
Obligate intracellular Coxiella burnetii is the causative agent
of human Q fever. Acute Q fever normally manifests as an
influenza-like illness, but approximately 50% of C. burnetii
infections are thought to be asymptomatic (52). Chronic Q
fever can occur and generally presents as endocarditis. These
cases are usually associated with individuals who are immuno-
suppressed and/or have heart valve defects (52). Host factors
are clearly involved in Q fever presentation (36). However,
there is also laboratory evidence suggesting that C. burnetii
isolates have distinct pathogenic potential. For example, the G
endocarditis isolate disseminates less and causes less inflam-
matory damage in BALB/c mice than the Nine Mile (NM)
reference isolate does (50). Additionally, some isolates derived
from infected mammals, such as the Priscilla goat isolate and
the Dugway rodent isolates, are attenuated relative to NM in a
guinea pig infection model of Q fever (26, 51).
In vivo, C. burnetii targets alveolar mononuclear phagocytes
and establishes a parasitophorous vacuole (PV) that displays
many characteristics of lysosomes (54). Early stages of infec-
tion are characterized by phagosome maturation stalling and
interaction with the autophagic pathway (18, 37). The matur-
ing PV eventually fuses with lysosomal compartments, as evi-
denced by acidification to approximately pH 5.0, acquisition of
the small GTPase Rab7, and decoration with lysosome-associ-
ated membrane proteins 1, 2, and 3 (54). Additionally, the PV
contains active lysosomal hydrolases (2). The mature PV can
eventually expand to occupy the majority of the host cell cy-
toplasm (54).
During infection, C. burnetii actively manipulates PV bio-
genesis and other host cell processes that presumably ensure a
stable replication niche for the duration of its lengthy infec-
tious cycle (12). For example, treatment of infected cells with
chloramphenicol, a bacterial protein synthesis inhibitor, im-
pedes formation of the large and spacious PV (19), interac-
tions with the autophagy pathway (37), and C. burnetii’s antag-
onism of host cell apoptosis (25, 55). Protein effectors of these
processes are likely delivered to the host cytosol by the organ-
ism’s Dot/Icm type IV secretion system (T4SS). C. burnetii
encodes 23 of the 26 Dot/Icm proteins found in Legionella
pneumophila (53). C. burnetii Dot/Icm genes are expressed
during infection, and four of them complement the corre-
sponding L. pneumophila mutants, including genes encoding
the chaperones IcmS and IcmW, indicating functional overlap
between the two systems (57, 58). L. pneumophila utilizes its
Dot/Icm T4SS to deliver proteins directly to the host cytosol,
where their diverse effector activities manipulate multiple host
cell processes (47). Over 70 Dot/Icm substrates have been
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identified for L. pneumophila, with the number continually
expanding (30). However, with a few possible exceptions (22),
C. burnetii does not encode homologs of these proteins. This
observation is consistent with the contrasting endoplasmic re-
ticulum-derived vacuole of L. pneumophila and the lysosome-
like compartment of C. burnetii (42).
Bacterial secretion of effector proteins that functionally
mimic the activities of eukaryotic proteins is a well-established
virulence mechanism used to manipulate a variety of host cell
processes, including cell survival signaling and vesicular traf-
ficking (7). Bioinformatic analyses of the C. burnetii NM isolate
genome have revealed multiple genes encoding proteins with
eukaryotic-type features, such as coiled-coil domains, tetratri-
copeptide repeats, and ankyrin repeats, that are candidate
Dot/Icm substrates (54). Genes encoding proteins with these
domains, which are generally rare in prokaryotes, are thought
to have arisen by interdomain horizontal gene transfer from a
eukaryotic source (15). Eukaryotic ankyrin repeat domain-con-
taining proteins (Anks) mediate protein-protein interactions
involved in a multitude of host processes, including cytoskel-
etal motility, tumor suppression, and transcriptional regulation
(27). Anks contain 33-residue repeating motifs consisting of
two antiparallel -helices connected to the next repeat via a
loop region (27). A series of repeats are arranged in a curved
structure, with protein-protein interactions occurring in the
loop regions. In addition to C. burnetii, Ank genes are present
in the facultative or obligate intracellular bacteria L. pneumo-
phila (15), Anaplasma phagocytophilum (9), Orientia tsutsuga-
mushi (10), Wolbachia pipientis (21), Rickettsia spp. (32), and
Rickettsiella grylli.
Using L. pneumophila as a surrogate host, Dot/Icm-medi-
ated secretion was recently demonstrated for C. burnetii AnkA,
-B, -F, and -G from the NM isolate (33). That study also
showed transcription of the encoding genes and secretion of
native AnkF during C. burnetii infection of Chinese hamster
ovary cells and human foreskin fibroblasts, respectively. The
initial C. burnetii NM isolate genome study reported the pres-
ence of 13 Ank genes (45). However, reannotation of the NM
isolate genome, along with compilation of the genomes of the
G and K human endocarditis isolates and a Dugway rodent
isolate, revealed that many NM Ank genes, including ankB, are
disrupted (6). Interestingly, many disrupted NM Ank genes are
intact in the G, K, and/or Dugway isolate. Moreover, these
isolates encode Anks that are missing in the NM isolate, lead-
ing to the intriguing possibility that isolate-specific Dot/Icm
secretion of effector proteins results in unique host cell re-
sponses.
In this study, we used the calmodulin-activated adenylate
cyclase (CyaA) from Bordetella pertussis as an enzymatic re-
porter (48) to monitor secretion of C. burnetii Anks carried by
the Dugway and K isolates. Using L. pneumophila as a surro-
gate host, we found that most intact C. burnetii Anks are
Dot/Icm substrates and that some, but not all, require the
chaperone IcmS for translocation into the host cytosol. More-
over, the Ank C-terminal 10 amino acids appear to be critical
for secretion. These proteins traffic to a variety of subcellular
locations when expressed ectopically in mammalian cells,
thereby providing clues about their possible function.
MATERIALS AND METHODS
Mammalian cell culture. THP-1 human monocyte-like cells (TIB-202; ATCC,
Manassas, VA) and HeLa (human epithelioid carcinoma) cells (CCL-2; ATCC)
were maintained in RPMI 1640 medium (Invitrogen, Carlsbad, CA) containing
10% fetal calf serum (Invitrogen) at 37°C and 5% CO2. Prior to infection, THP-1
cells were treated with 200 nM phorbol 12-myristate 13-acetate (PMA; EMD
Biosciences, San Diego, CA) to promote their differentiation into adherent,
macrophage-like cells as previously described (55).
C. burnetii, L. pneumophila, and R. grylli. The bacteria used in this study are
listed in Table 1. The C. burnetii NM phase II, clone 4 (RSA439), G (Q212), K
(Q154), and Dugway (5J108-111) isolates were propagated in Vero (African
green monkey kidney) cells (CCL-81; ATCC) and purified as previously de-
scribed (11, 46). L. pneumophila strains were generously provided by H. Shuman
(Columbia University) and were cultured on charcoal yeast extract (CYE) agar
plates for 2 days prior to genetic transformation and infection of THP-1 cells. For
plasmid selection, L. pneumophila transformants were grown in the presence of
chloramphenicol (10 g/ml). Mutant L. pneumophila strains (LELA3118 and
GS3001) were also cultured in the presence of 25 g/ml kanamycin. R. grylli-
infected Armadillidum vulgare insects (generously provided by B. Federici, Uni-
versity of California-Riverside) were homogenized, and DNAs were extracted
using a High Pure PCR template preparation kit (Roche Applied Science,
Indianapolis, IN).
Plasmid construction. The complete open reading frames of Ank genes were
amplified from C. burnetii, L. pneumophila, and R. grylli genomic DNAs by PCR,
using Accuprime Taq polymerase (Invitrogen) and gene-specific primers (Inte-
grated DNA Technologies, Coralville, IA), where the 5 primer incorporated a
BamHI or BglII site and the 3 primer incorporated a SalI or PstI site (Table 2).
Difficulty in cloning the entire C. burnetii ankH open reading frame necessitated
PCR-based cloning of a fragment encoding the C-terminal 216 residues of the
protein. The same cloning strategy was used to generate C. burnetii AnkI deletion
clones. Amplified gene products were cloned into pCR2.1-TOPO (Invitrogen)
and digested with either BamHI-SalI or BamHI-PstI (New England Biolabs,
Ipswich, MA), and the resulting fragments were ligated with similarly digested
pJB2581, using the Ligate-IT system (U.S. Biologicals, Cleveland, OH), to gen-
erate gene fusions encoding Anks N-terminally fused to the C terminus of CyaA.
To generate plasmids encoding Ank-mCherry fusion proteins, C. burnetii genes
were amplified by PCR, using gene-specific primers, and the amplicons were
directionally cloned into pENTR-D/TOPO (Invitrogen). Forward primers con-
tained CACC at the 5 end for directional cloning and a 5 Kozak sequence
(ATGGGC) for mammalian expression. Ank genes were subsequently subcloned
via homologous recombination into pcDNA6.2/N-mCherry or pcDNA6.2/C-
mCherry (generously provided by S. Grieshaber, University of Florida), using LR
Clonase II (Invitrogen). All plasmids encoding CyaA and mCherry fusion pro-
teins were sequenced to confirm in-frame cloning and are listed in Table 1.
Transformation of L. pneumophila. L. pneumophila JR32 (wild type), LELA3118
(DotA), and GS3001 (IcmS) were cultured on CYE agar. Bacteria were
washed from agar plates into 1 ml of DNase- and RNase-free water, washed two
more times in water, and then aliquoted for use in transformations. For each
transformation, 0.5 g of CyaA-Ank-encoding plasmid was added to 50 l of an
L. pneumophila suspension, and the mixture was electroporated in 0.1-cm
cuvettes at 1.8 kV/cm, 100 , and 25 F. Following electroporation, cultures
were incubated in ACES buffered yeast extract (AYE) broth in the absence of
antibiotics for 2 h at 37°C with shaking and then subcultured on CYE agar
containing the appropriate antibiotic for 4 to 5 days. Plasmids were isolated from
colonies, and clone-specific restriction enzyme digests were performed to con-
firm the presence of the expected restriction fragment.
Immunoblot analysis. Expression of CyaA-Ank fusion proteins by wild type,
DotA, and IcmS strains of L. pneumophila was verified by immunoblotting
(data not shown). Protein synthesis was induced by adding 1 mM isopropyl--
D-thiogalactopyranoside (IPTG; ICN Biomedicals, Costa Mesa, CA) to over-
night cultures of L. pneumophila transformants and incubating them for 2 h at
37°C with shaking. One milliliter of culture was centrifuged at 13,000  g for 5
min, the cell pellet was resuspended in sodium dodecyl sulfate-polyacrylamide
gel electrophoresis sample buffer, and then the proteins were separated via 10%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Proteins were trans-
ferred to an Immobilon-P membrane (Millipore, Bedford, MA), and membranes
were blocked for 1 h at room temperature in Tris-buffered saline (TBS; 150 mM
NaCl, 100 mM Tris-HCl, pH 7.6) containing 0.1% Tween 20 and 5% nonfat milk.
Membranes were then incubated for 1 h at room temperature in TBS plus Tween
20 containing a mouse monoclonal antibody directed against CyaA (clone 3D1;
Santa Cruz Biotechnology, Santa Cruz, CA). Membranes were washed and
incubated for 1 h at room temperature in TBS plus Tween 20 containing anti-
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mouse immunoglobulin G secondary antibody conjugated to horseradish perox-
idase (Pierce, Rockford, IL). Reacting proteins were detected via chemilumines-
cence using ECL Pico reagent (Pierce).
CyaA translocation assay. L. pneumophila transformants were cultured over-
night in AYE broth containing the appropriate antibiotic. PMA-differentiated
THP-1 cells were plated in 24-well plates (1  106 cells/well) and infected with
L. pneumophila expressing CyaA-Ank fusion proteins at a multiplicity of infec-
tion of approximately 20. Bacteria were added to wells, and the plate was
centrifuged for 5 min at 180 g to initiate contact between organisms and THP-1
cells. After a 30-min incubation at 37°C, cells were washed three times in
phosphate-buffered saline (PBS; 1 mM KH2PO4, 155 mM NaCl, 3 mM
Na2HPO4, pH 7.4) and lysed in 500 l of a solution containing 50 mM HCl and
TABLE 1. Bacteria and plasmids used in this study
Bacterial isolate or
strain or plasmid Genotype or description Reference or supplier
Strains
C. burnetii isolates
NM (RSA439) Phase II, clone 4, Montana, tick, 1936 5
G (Q212) Phase I, Nova Scotia, heart valve, 1981 5
K (Q154) Phase I, Oregon, heart valve, 1976 5
Dugway (5J108-111) Phase I, Utah, rodent, 1958 51
L. pneumophila strains
JR32 Salt-sensitive isolate of AM511 41
LELA3118 JR32 dotA::Tn903dIIlacZ3118 DotA Kmr 41
GS3001 JR32 icmS3001::Km IcmS Kmr 44
R. grylli B. Federici
E. coli TOP10 F mcrA 	(mrr-hsdRMS-mcrBC) 
80dlacZ	M15 	lacX74 recA1 araD139 	(ara-leu)7697
galU galK rpsL (Strr) endA1 nupG
Invitrogen
Plasmids
pJB2581 cyaA fusion vector; Cmr 4
pJB2590 ralF in pJB2581 4
pDHVAnkA ankA in pJB2581 This study
pDHVAnkB ankB in pJB2581 This study
pDHVAnkC ankC in pJB2581 This study
pDHVAnkD ankD in pJB2581 This study
pDHVAnkF ankF in pJB2581 This study
pDHVAnkG ankG in pJB2581 This study
pDHVAnkH ankH (bp 1927 to 2577) in pJB2581 This study
pDHVAnkI ankI in pJB2581 This study
pDHVAnkJ ankJ in pJB2581 This study
pDHVAnkK ankK in pJB2581 This study
pDHVAnkL ankL in pJB2581 This study
pDHVAnkM ankM in pJB2581 This study
pDHVAnkN ankN in pJB2581 This study
pDHVAnkO ankO in pJB2581 This study
pDHVAnkP ankP in pJB2581 This study
pDHVAnkB-K Isolate K ankB in pJB2581 This study
pDHVAnkI-NM Isolate NM ankI in pJB2581 This study
pDHVAnkI-82aaFrag ankI (bp 1932 to 2178) in pJB2581 This study
pDHVAnkI-10 ankI (bp 1 to 2148) in pJB2581 This study
pDHVAnkI-20 ankI (bp 1 to 2118) in pJB2581 This study
pDHVAnkI-30 ankI (bp 1 to 2088) in pJB2581 This study
pDHVAnkI-40 ankI (bp 1 to 2058) in pJB2581 This study
pDHVAnkI-60 ankI (bp 1 to 1998) in pJB2581 This study
pDHVAnkI-80 ankI (bp 1 to 1938) in pJB2581 This study
pDHVLpAnkK lpg2300 in pJB2581 This study
pDHVRg00379 rrgr00379 in pJB2581 This study
pDHVRg00660 rrgr00660 in pJB2581 This study
pDHVRgAnkK rrgr00938 in pJB2581 This study
pCR2.1-TOPO TA TOPO vector; Ampr Invitrogen
pENTR-D/TOPO Gateway entry vector; Kmr Invitrogen
pcDNA6.2/N-mCherry N-terminal mCherry fusion vector; Ampr S. Grieshaber
pcDNA6.2/C-mCherry C-terminal mCherry fusion vector; Ampr S. Grieshaber
mChAnkA-N mCherry::ankA This study
mChAnkA-C ankA::mCherry This study
mChAnkB-N mCherry::ankB This study
mChAnkB-C ankB::mCherry This study
mChAnkF-N mCherry::ankF This study
mChAnkF-C ankF::mCherry This study
mChAnkG-N mCherry::ankG This study
mChAnkG-C ankG::mCherry This study
mChAnkH-N mCherry::ankH This study
mChAnkH-C ankH::mCherry This study
mChAnkI-N mCherry::ankI This study
mChAnkI-C ankI::mCherry This study
mChAnkJ-N mCherry::ankJ This study
mChAnkJ-C ankJ::mCherry This study
mChAnkM-N mCherry::ankM This study
mChAnkM-C ankM::mCherry This study
mChAnkN-N mCherry::ankN This study
mChAnkN-C ankN::mCherry This study
mChAnkO-N mCherry::ankO This study
mChAnkO-C ankO::mCherry This study
mChAnkP-N mCherry::ankQ This study
mChAnkP-C ankQ::mCherry This study
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0.1% Triton X-100. Samples were boiled for 5 min, and 30 l of 0.5 M NaOH was
added to neutralize the acid. One milliliter of 95% ethanol was added to samples,
which were incubated on ice for 5 min, dried under a vacuum, and resuspended
in assay buffer (0.05 M sodium acetate [pH 5.8], 0.02% bovine serum albumin).
The level of cyclic AMP (cAMP) in dried samples was determined using a cAMP
enzyme immunoassay (GE Healthcare, Piscataway, NJ) according to the manu-
facturer’s protocol. CyaA-Ank fusions were considered positive for translocation
when the increase in cAMP over the level with CyaA alone (negative control)
TABLE 2. Primers used in this study
Primer name and use Sequencea
Primers for pJB2581 cloning
AnkA-F ..............................................................................................................................................CATGCGGATCCATGTTGCTTAGCTTAATGGCC
AnkA-R..............................................................................................................................................CGCATGCGTCGACTTAAAACAGTCCGGGGCCTG
AnkB-F...............................................................................................................................................CATGCAGATCTATGTTTAACCAATTGGAAATAGTG
AnkB-R ..............................................................................................................................................CGCATGCGTCGACTTACATGTGCTTACCCGGGG
AnkC-F...............................................................................................................................................CATGCGGATCCATGTTAATCCCGAGCCTCCAATC
AnkC-R..............................................................................................................................................CGCATGCGTCGACTTATTGCTGGGTTTCGTGATTGAC
AnkD-F ..............................................................................................................................................CATGCGGATCCATGCGTAAAAGTGAGTTACGAAAG
AnkD-R..............................................................................................................................................CGCATGCGTCGACTTACATAACCAGACAGTCCTCTG
AnkF-F...............................................................................................................................................CATGCGGATCCATGAGACAGCGTGAAATTAATG
AnkF-R ..............................................................................................................................................CGCATGCCTGCAGTTACTACCGCTGGAAGCCGC
AnkG-F ..............................................................................................................................................CATGCGGATCCATGAGTAGACGTGAGACTCCC
AnkG-R..............................................................................................................................................CGCATGCGTCGACTTATCACCGAGGACTAGACAG
AnkH-25-F.........................................................................................................................................CATGCGGATCCTTGGCTTGCGGTGATGGAACGACG
AnkH-R .............................................................................................................................................CGCATGCGTCGACTTAGATTAACGTGCGCGTATAATG
AnkI-F................................................................................................................................................CATGCGGATCCATGAGAGAATCATCAGAAAATC
AnkI-R ...............................................................................................................................................CGCATGCGTCGACTTACTAAATTCCAAAAGAACCC
AnkJ-F................................................................................................................................................CATGCGGATCCATGGCGAAATTTACTATACGTTTAG
AnkJ-R...............................................................................................................................................CGCATGCCTGCAGTTACGCAGCGCGCATGGTTTGTCG
AnkK-F ..............................................................................................................................................CATGCGGATCCATGAATTTATCAGACACGATTATC
AnkK-R..............................................................................................................................................CGCATGCGTCGACTTAAAATACCTCGTCCAGCTC
AnkL-F...............................................................................................................................................CATGCGGATCCATGCGGCCCGACCCCGC
AnkL-R ..............................................................................................................................................CGCATGCGTCGACTTACTAATTTTCTTTAACATCCTC
AnkM-F..............................................................................................................................................CATGCGGATCCATGGGTAATTTATTGAGTAAACG
AnkM-R.............................................................................................................................................CGCATGCCTGCAGTTACTAACCACACCGAAGCAG
AnkN-F ..............................................................................................................................................CATGCGGATCCATGAGCCGGACCTACAACGC
AnkN-R..............................................................................................................................................CGCATGCGTCGACTTAAATGCAAACCACCCGATTC
AnkO-F ..............................................................................................................................................CATGCGGATCCATGGAAATAATTTCCTTAATGAAG
AnkO-R..............................................................................................................................................CGCATGCGTCGACTTAATAACGATTTTTTGTTTCATAAAC
AnkP-F...............................................................................................................................................CATGCGGATCCATGGTGGGACAAAATACAACG
AnkP-R ..............................................................................................................................................CGCATGCGTCGACTTAAGCTAAGCAAGGGGTATTAC
AnkB-K-F ..........................................................................................................................................CATGCGGATCCATGAGACATCCCATAATTCACAAG
AnkB-K-R..........................................................................................................................................CGCATGCGTCGACTTATCAAAAAATTAGGACGCCATC
AnkI-NM-F........................................................................................................................................CATGCGGATCCATGAGAGAATCATCAGAAAATCAAAAAAAG
AnkI-NM-R .......................................................................................................................................CGCATGCGTCGACTTATTGCTTCAATGGAGGTACAC
AnkI-82aa-F.......................................................................................................................................GGATCCATGAGAGAATCATCAGAAAATCAAAAAAG
AnkI-10-R..........................................................................................................................................CTGCAGCTATTGGGATGAGGCGCTCGGA
AnkI-20-R..........................................................................................................................................CTGCAGCTATAACTTTTCTAAGCTTTTCCAAG
AnkI-30-R..........................................................................................................................................CTGCAGCTATTGTTTTTTTCCCCAAAATGCG
AnkI-40-R..........................................................................................................................................CTGCAGCTATGAGAGTTTCCTACATTTACTAATCG
AnkI-60-R..........................................................................................................................................CTGCAGCTATATTGCTTCAATGGAGGTACACTC
AnkI-80-R..........................................................................................................................................CTGCAGCTAGAAGGCGGGGCTATGAAC
LpAnkK-F..........................................................................................................................................CATGCGGATCCATGAGTATTGCAAACGATATTATC
LpAnkK-R .........................................................................................................................................CGCATGCGTCGACTTATAGGCCTGTCGCAACAGG
Rg00379-F..........................................................................................................................................CATGCGGATCCATGACCGCAATTAATATGTTAC
Rg00379-R .........................................................................................................................................CGCATGCGTCGACTTATGAAAGAAACGTTGATTCAATTGG
Rg00660-F..........................................................................................................................................CATGCGGATCCATGGATGTGCATGCCACTGATGCG
Rg00660-R .........................................................................................................................................CGCATGCGTCGACTTAAAATTTATAGGAAAGTTTTTTAC
RgAnkK-F .........................................................................................................................................CATGCGGATCCATGAATCATACGTTTGCACATG
RgAnkK-R.........................................................................................................................................CGCATGCGTCGACTTATAGCGTTACAACAACCCC
Primers for pENTR cloning
mChAnkA-F......................................................................................................................................CACCATGGGCTTGCTTAGCTTAATGGCCAGC
mChAnkA-R .....................................................................................................................................AAACAGTCCGGGGCCTGAATAATTG
mChAnkB-F ......................................................................................................................................CACCATGGGCTTTAACCAATTGGAAATAGTG
mChAnkB-R......................................................................................................................................CATGTGCTTACCCGGGG
mChAnkF-F.......................................................................................................................................CACCATGGGCAGACAGCGTGAAATTAATGATGAAG
mChAnkF-R......................................................................................................................................CCGCTGGAAGCCGCGATTATTTC
mChAnkG-F......................................................................................................................................CACCATGGGCAGTAGACGTGAGACTCCCAC
mChAnkG-R .....................................................................................................................................CCGAGGACTAGACAGACAAGAGAG
mChAnkH-F......................................................................................................................................CACCATGGGCTCAGAATTAGGAGGGGATGTTATTATC
mChAnkH-R .....................................................................................................................................GATTAACGTGCGCGTATAATGAGACTC
mChAnkI-F........................................................................................................................................CACCATGGGCAGAGAATCATCAGAAAATCAAAAAAG
mChAnkI-R.......................................................................................................................................AATTCCAAAAGAACCCGGCTC
mChAnkJ-F .......................................................................................................................................CACCATGGGCGCGAAATTTACTATACGTTTAG
mChAnkJ-R.......................................................................................................................................CGCAGCGCGCATGGTTTGTCG
mChAnkM-F .....................................................................................................................................CACCATGGGCGGTAATTTATTGAGTAAACGTCG
mChAnkM-R.....................................................................................................................................ACCACACCGAAGCAGAGAAGCCC
mChAnkN-F......................................................................................................................................CACCATGGGCAGCCGGACCTACAACGCAGC
mChAnkN-R .....................................................................................................................................AATGCAAACCACCCGATTCTTCC
mChAnkO-F......................................................................................................................................CACCATGGGCGAAATAATTTCCTTAATGAAGGC
mChAnkO-R .....................................................................................................................................ATAACGATTTTTTGTTTCATAAACTTTC
mChAnkP-F.......................................................................................................................................CACCATGGGCGTGGGACAAAATACAACGAGG
mChAnkP-R ......................................................................................................................................AGCTAAGCAAGGGGTATTACCTGC
a Underlining indicates restriction sites in primers.
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was at least 2.5-fold and this increase was abolished following expression of
fusion proteins in the L. pneumophila DotA mutant (LELA3118). A CyaA
fusion to RalF, a well-characterized L. pneumophila Dot/Icm effector (29), was
used as a positive control. cAMP levels resulting from translocation of CyaA-
RalF were similar to those reported by Bardill et al. (4).
Transfection and fluorescence microscopy. Confluent HeLa cells on 12-mm
glass coverslips were infected with C. burnetii NM phase II organisms for 24 h. At
24 h postinfection, cells were transfected with plasmids encoding Ank-mCherry
constructs, using Effectene reagent (Qiagen, Valencia, CA) according to the
manufacturer’s protocol. At 18 h posttransfection, cells were washed three times
in cold PBS and fixed in 100% methanol for 3 min at room temperature.
Following fixation, cells were washed three times in cold PBS and incubated with
DRAQ5 (Alexa Corporation, Lausanne, Switzerland) for 5 min to stain host and
bacterial DNA. Where indicated, cells were incubated with mouse monoclonal
antibodies directed against -tubulin (Sigma-Aldrich, St. Louis, MO) or CD63
(BD Biosciences, San Jose, CA) or with a rabbit polyclonal antibody directed
against COXIV (Cell Signaling, Danvers, MA). Binding of primary antibodies
was detected using anti-mouse or anti-rabbit secondary antibodies conjugated to
Alexa Fluor 488 (Molecular Probes, Carlsbad, CA). Confocal fluorescence mi-
croscopy was performed using a modified Perkin-Elmer UltraView spinning disk
confocal system connected to a Nikon Eclipse TE2000-S microscope. Images
were acquired with a 60 oil immersion objective (1.4 numerical aperture;
Nikon, Melville, NY) and a Photometrics Cascade II:512 digital camera (Prince-
ton Instruments, Trenton, NJ) using Metamorph software (Molecular Devices,
Downingtown, PA).
RESULTS
C. burnetii Ank genes display extensive heterogeneity among
isolates derived from disparate sources. The original GenBank
entry detailing the C. burnetii NM reference isolate genome
reported the presence of 13 Ank genes (45). However, rean-
notation of this genome, along with new genome sequencing
and annotation of the C. burnetii G, K, and Dugway isolates,
resulted in multiple changes in the NM Ank gene family (6)
(Fig. 1). Immediately downstream of NM ankA is the newly
annotated gene ankP, which has a frameshift mutation. In
addition to ankP, NM ankH, -L, and -M are now recognized as
fragmented genes. ankD (CBU0355) and the previously anno-
tated downstream gene ankE (CBU0356) are now known to
constitute a single frameshift mutant gene that is denoted
ankD. Lineups of the C. burnetii Ank gene family revealed that
the Dugway isolate encodes 11 intact Anks (encoded by ankA,
-C, -D, -F, -G, -H, -I, -K, -M, -O, and -P), while the NM isolate
encodes only 5 (encoded by ankA, -C, -F, -G, and -K). Ank
genes were considered disrupted if they contained a frame-
shift(s) or a 3 deletion relative to a full-length ortholog carried
by another C. burnetii isolate and were named according to the
nomenclature of Pan et al. (33). ankD, -H, and -O are intact
only in the Dugway isolate, with ankO being unique to Dug-
way. ankA, -I, -M, and -P are intact in Dugway and either the
G or K isolate. ankN is intact only in the G and K endocarditis
isolates. Although at first glance ankL of the Dugway isolate
appears to be a full-length gene, a small ankL gene fragment in
the G isolate extends beyond the 3 end of the Dugway or-
tholog, suggesting that Dugway ankL is truncated at the 3 end.
Along with ankL, ankB and ankJ appear to be disrupted in all
isolates, with both genes containing frameshifts that result in
small gene fragments at the 5 end. However, these fragments
do not encode proteins with ankyrin repeat domains, leading to
the possibility that the larger fragments of ankB and ankJ,
which do encode ankyrin repeats, may be transcribed into
functional proteins. Interestingly, only ankC, -F, and -K appear
to be conserved as full-length genes in all four isolates. Al-
though ankG from the K isolate contains a 5 truncation, this
truncation is not the result of a frameshift, suggesting that this
gene is still functional. The number of repeats in each C.
burnetii Ank was highly variable and ranged from 1 in AnkJ to
14 in AnkH (Fig. 2). At least two neighboring repeats are
required for a functional protein-protein interaction domain
(27); therefore, AnkJ is predicted to contain a nonfunctional
repeat. Only AnkD contained an additional eukaryotic motif,
with an F-box domain located in its N terminus (Fig. 2).
Multiple C. burnetii Anks are translocated into the host
cytosol in a Dot/Icm-dependent manner. Methods for gene-
specific genetic manipulation of C. burnetii are currently not
available. Therefore, we used L. pneumophila as a surrogate
host to examine Dot/Icm-directed translocation of C. burnetii
Anks. Unless otherwise indicated, all Anks examined in the
current study were from the Dugway isolate, except for AnkN,
which was from the K isolate. Based on reports indicating that
the translocation signal for most L. pneumophila Dot/Icm sub-
strates is located at the C terminus (8, 28), plasmids were
constructed to encode C. burnetii Anks N-terminally fused to
the C terminus of CyaA from Bordetella pertussis. Due to dif-
ficulty in expressing full-length AnkH, the C-terminal 216 res-
idues (25% of the intact protein) were expressed as a CyaA
fusion protein. PMA-differentiated THP-1 macrophage-like
cells were infected with L. pneumophila strains producing each
fusion protein, and intracellular cAMP levels were measured.
As shown in Fig. 3, cAMP levels were substantially increased
relative to that in L. pneumophila expressing CyaA alone (neg-
ative control) when cells were infected with bacteria producing
AnkA, -B, -F, -G, -H, -I, -J, -M, -N, -O, and -P, indicating that
these Anks are delivered to the host cytosol. Translocation of
Dugway AnkA, -B, -F, and -G was consistent with the results of
Pan et al. (33), who reported translocation of the orthologous
proteins from the NM isolate. However, unlike the case in that
report, we also observed translocation of AnkJ.
Wild-type L. pneumophila JR32 encodes non-Dot/Icm secre-
tion systems (43). Therefore, to verify that C. burnetii Anks are
translocated in a Dot/Icm-dependent fashion, constructs that
resulted in positive CyaA translocation were introduced into a
DotA mutant of L. pneumophila, which is deficient in Dot/
Icm type IV secretion (13, 39–41), and the CyaA assay was
repeated. As shown in Fig. 3, cAMP levels approximated that
of the negative control in the absence of DotA, indicating that
translocation is directed by Dot/Icm.
L. pneumophila and R. grylli homologs of C. burnetii AnkK
are not secreted by L. pneumophila. AnkK, which is full length
in all four C. burnetii isolates, was not translocated by the L.
pneumophila Dot/Icm T4SS. Proteins that are 41% and 39%
identical to AnkK at the amino acid level are present in L.
pneumophila and R. grylli, respectively. R. grylli is an obligate
intracellular pathogen of insects, arachnids, and isopods that is
closely related to C. burnetii (38) and carries 19 of the 26 L.
pneumophila Dot/Icm components (23). To ascertain whether
either C. burnetii AnkK homolog is secreted, each protein was
tested in the CyaA assay. Neither protein was translocated by
L. pneumophila (data not shown), suggesting that their func-
tion is not associated with secretion. Moreover, two additional
R. grylli Anks, Rg00379 and Rg00660, were not secreted by L.
pneumophila (data not shown). A lack of L. pneumophila
4236 VOTH ET AL. J. BACTERIOL.
AnkK secretion is consistent with results reported by de Felipe
et al. (15).
A subset of C. burnetii Anks requires the Dot/Icm chaperone
IcmS for translocation. Chaperone proteins are required for
efficient delivery of some effectors to the Dot/Icm apparatus
prior to translocation into the host cytosol (30). IcmS is a
well-characterized chaperone of L. pneumophila Dot/Icm ef-
fector proteins (4, 8), and C. burnetii icmS complements L.
pneumophila IcmS mutants (57, 58). To examine whether
IcmS is required for translocation of C. burnetii Anks, CyaA-
positive Ank constructs were introduced into an IcmS-deficient
L. pneumophila mutant and tested for secretion in the CyaA
assay. As shown in Fig. 4, translocation of AnkB, -H, -I, -J, -M,
-N, and -O, but not that of AnkA, -F, -G, or -P, was dramat-
ically inhibited in the absence of functional IcmS. These data
indicate that IcmS is required for translocation of some, but
not all, C. burnetii Anks.
The C. burnetii Ank Dot/Icm translocation signal is located
in the C terminus. Multiple studies indicate that the C termi-
nus of L. pneumophila Dot/Icm substrates contains a signal
required for secretion (8, 28). To determine if this requirement
extends to C. burnetii effector proteins, AnkB and AnkI from
FIG. 1. C. burnetii Anks display considerable heterogeneity among isolates derived from disparate sources. Ank genes from the NM, G, K, and
Dugway isolates were compared and placed into 15 groups. The Ank gene orthologs present in each isolate are designated by colors, as defined
in the key. Arrows represent either whole genes or a gene fragment. White arrows denote Ank gene fragments that were discovered through
reannotation of the NM isolate genome sequence. The NM isolate contains the fewest intact Ank genes (5), while the Dugway isolate carries the
most intact Ank genes (11). Disrupted Ank genes from the NM isolate typically contained frameshift mutations resulting in truncations. ankN and
ankO (boxed area) are absent as full-length or fragmented genes in the NM isolate.
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the K and NM isolates, respectively, were tested for secretion.
These Anks each have a 69-amino-acid C-terminal truncation
relative to the Dugway orthologs (Fig. 5A). As shown in Fig.
5B, neither truncated Ank was translocated into the host cy-
tosol by L. pneumophila. To further define the Dugway isolate
AnkI translocation signal, CyaA fusions to the AnkI protein
missing 10, 20, 30, 40, 60, or 80 amino acids from its C terminus
were tested for translocation. None of these fusion proteins
were translocated (Fig. 5B and data not shown). Conversely, a
CyaA fusion to the C-terminal 82 amino acids of AnkI was
translocated (Fig. 5B). Collectively, these data indicate that the
C-terminal 82 amino acids of AnkI are sufficient for secretion,
with the C-terminal 10 amino acids being required.
C. burnetii Anks localize to distinct subcellular regions when
expressed ectopically in HeLa cells. L. pneumophila Dot/Icm
substrates commonly localize to distinct intracellular sites/or-
ganelles, including the pathogen-containing vacuole, where
they can modulate host cell functions associated with the re-
spective subcellular compartment (14, 56). Therefore, to pro-
vide insight into C. burnetii Ank function, each translocation-
positive Ank was expressed ectopically in C. burnetii-infected
HeLa cells as an N- or C-terminal fusion to red fluorescent
mCherry, and localization was visualized by confocal fluores-
cence microscopy. The orientation of the mCherry fusion tag
did not demonstrably alter intracellular Ank trafficking. AnkA,
-B, -F, -H, -I, -M, and -P showed diffuse localization in the host
cytoplasm (Fig. 6 and data not shown). Conversely, AnkG
FIG. 2. C. burnetii Anks contain various numbers of ankyrin re-
peats. Anks were examined using Pfam and Interpro to identify repeat
regions. Each circle represents one ankyrin repeat, and the numbers
above and below the circle denote amino acid residues. The box indi-
cates an F-box domain present in AnkD. The number to the right of
each Ank indicates the total number of amino acid residues in each
protein. All Anks examined were from the Dugway isolate, except for
AnkN, which was from the K isolate. C. burnetii Anks contained as few
as 1 (AnkJ) and as many as 14 (AnkH) repeats.
FIG. 3. Multiple C. burnetii Anks are translocated into the host
cytosol in a Dot/Icm-dependent manner. Intracellular levels of cAMP
were determined following infection of THP-1 cells with L. pneumo-
phila strains expressing CyaA-Ank fusion proteins. The results are
expressed as changes in the cAMP level compared to that resulting
from infection with L. pneumophila expressing CyaA alone. L. pneu-
mophila expressing the characterized Dot/Icm substrate RalF fused to
CyaA was used as a positive control. All Anks examined were from the
Dugway isolate, except for AnkN, which was from the K isolate. Ele-
vated levels of cAMP were observed after infection by L. pneumophila
cells expressing 11 different C. burnetii Anks (black bars), indicating
translocation into the host cytosol. Basal levels of cAMP were ob-
served when these Anks were expressed in DotA-deficient L. pneumo-
phila (gray bars), indicating that secretion requires a functional Dot/
Icm T4SS. Experiments were performed in triplicate, and error bars
represent standard deviations from the means.
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localized to cytoskeleton-like filamentous structures (Fig. 6).
Immunostaining with a monoclonal antibody directed against
-tubulin identified these structures as microtubules. AnkJ
trafficked to mitochondria, as evidenced by colocalization with
COXIV, a host protein that resides in the inner leaflet of the
mitochondrial membrane (Fig. 6). AnkN and AnkO localized
to the C. burnetii PV membrane and to vesicular bodies that
colabeled with the lysosomal marker CD63 (Fig. 6 and data not
shown).
DISCUSSION
The Ank gene family displays striking heterogeneity be-
tween C. burnetii isolates, with the naturally attenuated Dug-
way isolate containing the most intact Ank genes. Here we
demonstrated that most Dugway Anks and AnkN of the K
endocarditis isolate are translocated into the host cytosol by L.
pneumophila in a Dot/Icm-dependent fashion. We also show
that Anks traffic to distinct host cell regions when expressed
ectopically, suggesting that they modulate diverse cellular
functions through interactions with host factors at these sub-
cellular sites.
Anks were originally described for eukaryotes as mediators
of diverse protein-protein interactions. However, genome se-
quencing recently revealed Ank genes in at least nine bacterial
species that replicate inside host cells (10, 17, 21, 24, 32), with
O. tsutsugamushi encoding 50 Anks (10). The common occur-
rence of Anks in intracellular pathogens suggests a critical role
for this protein family in successful host cell parasitism. In-
deed, two recent reports demonstrated a role for three L.
pneumophila Anks during pathogen growth in human mono-
cyte-derived macrophages (3, 17). Moreover, five L. pneumo-
phila Anks are translocated into the host cytosol, among which
AnkX disrupts microtubule-mediated trafficking events (3, 33).
Three distinct cellular activities have been described for AnkA
of A. phagocytophilum during growth of the pathogen in neu-
trophils (20, 24, 34). One activity involves binding of eukaryotic
chromatin to potentially influence host gene expression (34).
The second activity involves binding to Abl interactor 1, an
adaptor protein that engages the eukaryotic tyrosine kinase
Abl-1 (24). This interaction results in phosphorylation of
AnkA and is important for the infectious process of A. phago-
cytophilum. Finally, the third activity involves direct binding to
the eukaryotic phosphatase SHP-1 that may alter cellular sig-
naling early during A. phagocytophilum infection (20).
Only C. burnetii AnkK has apparent bacterial homologs,
with L. pneumophila and R. grylli proteins exhibiting approxi-
mately 40% identity. Habyarimana et al. recently showed that
AnkK-deficient L. pneumophila is impaired for growth in hu-
man monocyte-derived macrophages (17). Here we demon-
strated that AnkK homologs are not secreted by L. pneumo-
phila, suggesting that these proteins function in a conserved
bacterial process not requiring delivery to the host cytosol. Our
findings agree with those of de Felipe et al., who showed that
L. pneumophila AnkK is not secreted during infection of Dic-
tyostelium cells (15), but differ from those of Pan et al., who
demonstrated low levels of protein translocation during L.
pneumophila infection of Chinese hamster ovary cells (33). In
addition to AnkK, R. grylli encodes eight unique Anks. Two of
these proteins, Rg00379 and Rg00660, are also not translo-
cated by L. pneumophila. R. grylli Anks may be bona fide T4SS
substrates but may lack the translocation signal and/or chap-
erone interactions required for secretion by L. pneumophila.
Moreover, given the incomplete nature of the R. grylli Dot/Icm
FIG. 4. A subset of C. burnetii Anks require the chaperone IcmS
for translocation. Each C. burnetii translocation-positive Ank was ex-
pressed in wild-type L. pneumophila or an IcmS-deficient strain, and
cAMP levels were determined following infection of THP-1 cells.
AnkB, -H, -I, -J, -M, -N, and -O required functional IcmS for trans-
location. In contrast, AnkA, -F, -G, and -P were delivered to the
cytosol in the absence of IcmS. Experiments were performed in trip-
licate, and error bars represent the standard deviations from the
means.
FIG. 5. The Ank translocation signal is located in the C terminus.
(A) AnkB from the K isolate and AnkI from the NM isolate lack 69
amino acids at their C termini compared to the Dugway orthologs.
(B) Dugway isolate AnkB and AnkI, but not K and NM isolate AnkB
and AnkI, respectively, were translocated as CyaA fusion proteins by
wild-type L. pneumophila. CyaA-AnkI644–762, a fusion protein contain-
ing the C-terminal 82 amino acids of Dugway AnkI, was also translo-
cated, whereas CyaA-AnkI1–716, a fusion protein lacking the C-termi-
nal 10 amino acids of Dugway AnkI, was not translocated. With the
exception of those with the Dugway AnkI truncations, experiments
were performed in triplicate and error bars represent the standard
deviations from the means. The results of Dugway AnkI truncation
experiments are representative of those obtained from two experi-
ments, and error bars indicate the standard errors from the means.
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FIG. 6. AnkG, -J, and -N localize to distinct subcellular regions in HeLa cells. Each translocation-positive Ank was expressed ectopically in
HeLa cells as an N- or C-terminal fusion to mCherry. Trafficking of ectopically expressed C-terminal fusion proteins is shown. HeLa cells infected
with C. burnetii for 30 h were transfected with each construct for 18 h. Cells were subsequently fixed and processed for confocal fluorescence
microscopy. In each merged panel, mCherry fluorescence is shown in red, DNA stained with DRAQ5 is shown in blue, and antibody-stained
structures are shown in green. AnkA-mCherry localized diffusely throughout the host cytoplasm. AnkG-mCherry colocalized with microtubules,
as evidenced by fluorescence overlap with antibody-stained -tubulin. AnkJ-mCherry colocalized with mitochondria, as shown by fluorescence
overlap with antibody-stained COXIV. AnkN-mCherry localized to lysosomal compartments, including the C. burnetii PV membrane, as evidenced
by fluorescence overlap with antibody-stained CD63. Arrowheads denote C. burnetii PV. Bar, 10 m.
4240 VOTH ET AL. J. BACTERIOL.
gene complement relative to those of L. pneumophila and C.
burnetii, it is unclear whether this system constitutes a func-
tional T4SS. The absence of the other C. burnetii Anks in other
bacterial species suggests that they modulate host cell events
specific to C. burnetii infection.
The L. pneumophila chaperones IcmS and IcmW play a
critical role in efficient delivery of some effectors to the Dot/
Icm apparatus (4, 8). Indeed, IcmW has been used as a bait in
yeast two-hybrid assays to identify novel L. pneumophila Dot/
Icm substrates, indicating the direct binding of this protein to
effectors (31). C. burnetii AnkA, -F, -G, and -P, but not AnkB,
-H, -I, -J, -M, -N, and -O, are translocated into the cytosol by
an L. pneumophila IcmS mutant. These data suggest that
other chaperone complexes, such as IcmQ/IcmR, may be used
for translocation of these effectors. In support of this hypoth-
esis, recent evidence shows that some L. pneumophila effectors
are translocated in an IcmS-independent fashion (8). Although
C. burnetii lacks IcmR, an IcmR functional homolog, CoxigA
(CBU1634a), directly interacts with IcmQ and may function in
an IcmR-like manner (16).
The translocation signal of L. pneumophila Dot/Icm sub-
strates is thought to reside in the effector protein C terminus
(8, 28). This region contains a disordered segment that may be
stabilized by effector interactions with IcmS/IcmW (8). A dif-
ferent mechanism is proposed for A. phagocytophilum AnkA,
where a C-terminal translocation signal consisting of basic
amino acid residues (arginine and lysine) may provide a hy-
drophilic “tail” for delivery to the secretion complex (24). The
translocation signal for C. burnetii Anks also appears to be
located C-terminally. AnkB and AnkI of the K and NM iso-
lates, respectively, which lack 69 amino acids at their C termini
relative to the full-length orthologs in the Dugway isolate, are
not secreted. Moreover, removal of as little as 10 amino acids
from the C terminus of Dugway AnkI abolishes translocation.
This 10-amino-acid motif (NTSEPGSFGI) is not conserved
among C. burnetii Anks; thus, the disordered signal hypothesis
(8) may apply for the subset of Anks, such as AnkB and AnkI,
that rely on IcmS for translocation.
Secreted bacterial virulence factors often traffic to distinct
cellular locations, where they modulate host processes during
infection (14, 49). Ectopically expressed AnkG, -J, -N, and -O
localize to specific cellular sites, while the other C. burnetii
Anks disperse throughout the cytoplasm. AnkG localizes to
host microtubules, suggesting that this effector modulates a
microtubule-mediated function, such as PV movement to the
perinuclear region or delivery of vesicular cargo to the vacuole.
A similar function has been demonstrated for the Salmonella
enterica type III secretion system effector SseF, which interacts
with the microtubule motor protein dynein to promote proper
positioning of the S. enterica-containing vacuole during epithe-
lial cell infection (1). Interestingly, disruption of HeLa cell
microtubules with nocodazole inhibits formation of the large
and spacious PV, indicating a critical role for microtubules in
vacuole biogenesis (D. E. Voth and R. A. Heinzen, unpub-
lished data). ankG is conserved as an intact gene in the NM, G,
and Dugway isolates, while ankG from the K isolate contains a
5 truncation. However, the absence of a frameshift mutation
suggests that ankG from the K isolate encodes a functional
protein. Thus, AnkG activity may absolutely be required for
successful C. burnetii infection. Interestingly, AnkC and AnkK
are also conserved among all four isolates but are not secreted.
However, the possibility exists that these Anks are false-nega-
tive proteins that are not translocated by L. pneumophila in the
CyaA assay. AnkJ localizes to mitochondria, where it may
modulate the apoptotic functions of this organelle. Indeed,
members of our laboratory and others recently demonstrated
that C. burnetii potently inhibits mitochondrion-mediated ap-
optosis (25, 55). AnkN and AnkO localize to the PV mem-
brane, where they might mediate vesicular fusion events re-
quired for PV maturation. A similar activity is associated with
the L. pneumophila Dot/Icm substrates SidC and SdcA, which
attach to the membrane of the pathogen-containing vacuole
and mediate recruitment of the endoplasmic reticulum mem-
brane (35, 56).
In summary, identification of secreted C. burnetii virulence
factors has been difficult due to a lack of systems to genetically
manipulate the organism. By taking advantage of the evolu-
tionarily related Dot/Icm T4SSs of L. pneumophila and C.
burnetii, we have identified a large and diverse family of Ank
proteins that are Dot/Icm substrates. Based on ectopic expres-
sion results, native Anks are predicted to traffic to specific
subcellular sites, where they likely mimic or disrupt the activ-
ities of host factors to promote pathogen growth. The NM
isolate, with the fewest intact Ank genes, is significantly more
virulent in a guinea pig infection model of acute Q fever than
the Dugway isolate, which contains the most intact Ank genes
(51; J. E. Samuel, unpublished data). Thus, it is intriguing to
speculate that Ank gene content plays a role in C. burnetii
pathotype-specific virulence. Determining the definitive role
for Anks in C. burnetii pathogenesis awaits gene knockout
studies and subsequent animal challenge.
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